These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12831303)

  • 1. [Prognostic factors, mortality and pneumococcal vaccination recommendations in bacteriemica pneumococcal pneumonia].
    Jover Díaz F; Andreu Giménez L; Roig Rico P; Cañizares Navarro R; Ortiz de La Tabla V; Cuadrado Pastor JM
    An Med Interna; 2003 May; 20(5):269-70. PubMed ID: 12831303
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pneumococcal infections. Every second fatality within 48 hours].
    MMW Fortschr Med; 2001 Nov; 143(47):60. PubMed ID: 11791369
    [No Abstract]   [Full Text] [Related]  

  • 3. Pneumococcal vaccination in adults: recommendations, trends, and prospects.
    Targonski PV; Poland GA
    Cleve Clin J Med; 2007 Jun; 74(6):401-6, 408-10, 413-4. PubMed ID: 17569198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Vaccination of the elderly against pneumococcal disease is cost-efficient. Mass vaccination of all aged 65 and over is recommended].
    Ortqvist A; Jönsson B; Baltussen R; Ament A
    Lakartidningen; 2000 Nov; 97(45):5120-5. PubMed ID: 11116891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventing pneumococcal disease. ACIP recommends pneumococcal polysaccharide vaccine for all adults age > or = 65.
    Whitney CG
    Geriatrics; 2003 Oct; 58(10):20-2, 25. PubMed ID: 14569639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pneumococcal bacteraemia and opportunities for prevention.
    Drinkovic D; Wong CG; Taylor SL; Roberts SA; Morris AJ
    N Z Med J; 2001 Jul; 114(1136):326-8. PubMed ID: 11548097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recommendations for prevention of community-acquired pneumonia with bacteremia as the leading form of invasive pneumococcal infections in the population of people over 50 years of age and risk groups above 19 years of age].
    Albrecht P; Antczak A; Hryniewicz W; Skoczyńska A; Radzikowski A; Kedziora-Kornatowska K; Bernatowska E; Stompór T; Grodzicki T; Gyrczuk E; Imiela J; Jedrzejczak W; Windak A
    Pol Merkur Lekarski; 2014 Feb; 36(212):79-87. PubMed ID: 24720101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New pneumococcal-vaccine recommendations include strategies for increasing vaccine use.
    Am J Health Syst Pharm; 1997 Aug; 54(15):1688. PubMed ID: 9262738
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevention of pneumococcal disease through vaccination.
    Gentile A; Bazán V
    Vaccine; 2011 Sep; 29 Suppl 3():C15-25. PubMed ID: 21896348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pneumococcal conjugate vaccine for young children.
    Selman S; Hayes D; Perin LA; Hayes WS
    Manag Care; 2000 Sep; 9(9):49-52, 54, 56-7 passim. PubMed ID: 11116663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pneumococcal immunization of hospitalized patients.
    Ordin D
    Med Health R I; 2003 Aug; 86(8):258-9. PubMed ID: 14587468
    [No Abstract]   [Full Text] [Related]  

  • 12. Invasive pneumococcal disease and the potential for prevention by vaccination in the United Kingdom.
    Parsons HK; Metcalf SC; Tomlin K; Read RC; Dockrell DH
    J Infect; 2007 May; 54(5):435-8. PubMed ID: 17052760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community-acquired bacteraemic pneumococcal pneumonia in adults: effect of diminished penicillin susceptibility on clinical outcome.
    Bonnard P; Lescure FX; Douadi Y; Schmit JL; Jounieaux V; Laurans G; Eb F; Ducroix JP
    J Infect; 2005 Jul; 51(1):69-76. PubMed ID: 15979494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pneumococcus (including childhood immunization) immunization/prophylaxis: recommendations for adults/older adults.
    Nurse Pract; 1997 Feb; 22(2):110-3. PubMed ID: 9055320
    [No Abstract]   [Full Text] [Related]  

  • 15. Effectiveness of pneumococcal polysaccharide vaccine in older adults.
    Jackson LA; Neuzil KM; Yu O; Benson P; Barlow WE; Adams AL; Hanson CA; Mahoney LD; Shay DK; Thompson WW;
    N Engl J Med; 2003 May; 348(18):1747-55. PubMed ID: 12724480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people.
    Sisk JE; Moskowitz AJ; Whang W; Lin JD; Fedson DS; McBean AM; Plouffe JF; Cetron MS; Butler JC
    JAMA; 1997 Oct 22-29; 278(16):1333-9. PubMed ID: 9343464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 23-valent pneumococcal polysaccharide vaccine is effective in elderly adults over 75 years old--Taiwan's PPV vaccination program.
    Tsai YH; Hsieh MJ; Chang CJ; Wen YW; Hu HC; Chao YN; Huang YC; Yang CT; Huang CC
    Vaccine; 2015 Jun; 33(25):2897-902. PubMed ID: 25936662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACIP's new recommendation for pneumococcal vaccines for all adults 65 years and older.
    Kelly M; Coffin J
    J Med Assoc Ga; 2015; 104(1):24-5. PubMed ID: 26492748
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical characteristics and outcomes of pneumococcal bacteremia in adult patients with liver cirrhosis.
    Choi SH; Park HG; Jun JB; Lee SO; Choi SH; Woo JH; Kim YS
    Diagn Microbiol Infect Dis; 2009 Feb; 63(2):160-4. PubMed ID: 19150708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thousand faces of Streptococcus pneumonia (pneumococcus) infections].
    Szabó BG; Lénárt KS; Kádár B; Gombos A; Dezsényi B; Szanka J; Bobek I; Prinz G
    Orv Hetil; 2015 Nov; 156(44):1769-77. PubMed ID: 26498896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.